SCYNEXIS Depreciation & Amortization 2011-2026 | SCYX

Annual Depreciation & Amortization SCYNEXIS

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	580 K	606 K	379 K	111 K	111 K	53 K	41 K	26 K	447 K	1.24 M	1.33 M	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
1.33 M	26 K	447 K

Quarterly Depreciation & Amortization SCYNEXIS

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	-	-	-	-	-	-	-	-	151 K	-	451 K	301 K	155 K	-	133 K	85 K	27 K	-	82 K	54 K	28 K	-	85 K	59 K	29 K	-	19 K	2 K	1 K	-	40 K	39 K	1 K	-	11 K	7 K	3 K	-	447 K	124 K	323 K	-	303 K	307 K	308 K	-	321 K	343 K	347 K	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
451 K	1 K	148 K

Depreciation & Amortization of other stocks in the Drug manufacturers industry

Issuer	Depreciation & Amortization	Price	% 24h	Market Cap	Country
AcelRx Pharmaceuticals ACRX	311 K	-	7.5 %	$ 6.35 M	USA
Agile Therapeutics AGRX	102 K	-	10.11 %	$ 58.2 M	USA
Adamis Pharmaceuticals Corporation ADMP	1.48 M	-	0.86 %	$ 117 M	USA
Aerie Pharmaceuticals AERI	6.4 M	-	-	$ 754 M	USA
Catalent CTLT	489 M	-	-	$ 11.5 B	USA
Eagle Pharmaceuticals EGRX	646 K	-	-39.89 %	$ 27.7 M	USA
Endo International plc ENDP	306 M	-	-	$ 28.9 M	Irlanda
DURECT Corporation DRRX	31 K	-	-	$ 50.1 M	USA
Alimera Sciences ALIM	8.75 M	-	-	$ 142 M	USA
Athenex ATNX	4.47 M	-	-23.39 %	$ 1.76 M	USA
Avadel Pharmaceuticals plc AVDL	2.68 M	-	-	$ 2.06 B	France
Cumberland Pharmaceuticals CPIX	4.9 M	$ 3.23	3.53 %	$ 45.4 M	USA
Bausch Health Companies BHC	1.26 B	$ 5.76	0.7 %	$ 2.1 B	Canada
Tilray TLRY	35.7 M	$ 6.94	3.2 %	$ 4.29 B	Canada
Harrow Health HROW	1.32 M	$ 38.63	4.12 %	$ 1.42 B	USA
Canopy Growth Corporation CGC	21.5 M	$ 1.08	-	$ 116 M	Canada
Veru VERU	268 K	$ 2.41	1.26 %	$ 325 M	USA
Jupiter Wellness JUPW	654 K	-	-	$ 33.6 M	USA
Viatris VTRS	2.74 B	$ 13.99	1.12 %	$ 16.8 B	USA
Lannett Company LCI	34.3 M	-	1.15 %	$ 7.11 M	USA
Neoleukin Therapeutics NLTX	3.04 M	-	-	$ 193 M	Canada
Evolus EOLS	7.51 M	$ 4.39	1.27 %	$ 283 M	USA
Emergent BioSolutions EBS	125 M	$ 8.82	6.98 %	$ 452 M	USA
Organogenesis Holdings ORGO	13.6 M	$ 2.48	3.99 %	$ 327 M	USA
Pacira BioSciences PCRX	78.8 M	$ 24.08	0.06 %	$ 1.11 B	USA
PetIQ PETQ	44.5 M	-	1.64 %	$ 400 M	USA
ProPhase Labs PRPH	4.72 M	-	-	$ 5.07 M	USA
Relmada Therapeutics RLMD	1.26 K	$ 7.48	1.36 %	$ 295 M	USA
Assertio Holdings ASRT	30 M	$ 18.03	0.03 %	$ 115 M	USA
Radius Health RDUS	1.16 M	-	-	$ 1.42 B	USA
Recro Pharma REPH	8.22 M	-	-4.76 %	$ 65.3 M	USA
cbdMD YCBD	452 K	$ 0.73	-2.0 %	$ 3.15 M	USA
OptiNose OPTN	402 K	-	-	$ 1.08 B	USA
PLx Pharma PLXP	116 K	-	-27.8 %	$ 2.56 M	USA
Solid Biosciences SLDB	1.64 M	$ 8.68	3.46 %	$ 760 M	USA
Sonoma Pharmaceuticals SNOA	138 K	$ 2.44	3.62 %	$ 3.03 M	USA
Zomedica Corp. ZOM	2.06 M	-	-0.21 %	$ 98 M	USA
Zynerba Pharmaceuticals ZYNE	219 K	-	-	$ 55.5 M	USA
Rockwell Medical RMTI	2.19 M	$ 0.92	-2.1 %	$ 33.1 M	USA
Tricida TCDA	442 K	-	-	$ 3.25 M	USA
China Pharma Holdings CPHI	1.5 M	$ 0.63	-3.05 %	$ 2.7 M	China
TherapeuticsMD TXMD	384 K	$ 2.15	5.12 %	$ 24.9 M	USA